Sharps Technology Inc. (STSS)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch STSS
See up to 3 months of STSS. The 7-day demo opens the 1M and 3M ranges and puts STSS on your watchlist.
Start 7-day demoLatest STSS insider trades
About Sharps Technology Inc. (STSS)
The SEC lists Sharps Technology Inc. under CIK 0001737995, in surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
STSS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 44,000 | $78K |
STSS insider transactions (Form 4)
4615 Form 4 filings on record, the earliest from Dec 5, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bastion Trading Ltd - 10% Owner | Open-market purchase | Common Stock, par value $0.0001 per share | 44,000 footnote F3 | $1.78 footnote F2 | $78K | |
| ||||||
| FalconX Holdings Ltd | Open-market sale | Common Stock | 269,321 | $1.93 | $519K | |
| FalconX Holdings Ltd | Open-market sale | Common Stock | 260,411 | $1.93 | $501K | |
| FalconX Holdings Ltd | Other | Common Stock | 461,538 | $0.00 | $46 | |
| FalconX Holdings Ltd | Open-market sale | Common Stock | 192,307 | $1.97 | $378K | |
| FalconX Holdings Ltd | Open-market sale | Common Stock | 47,281 | $1.97 | $93K | |
| FalconX Holdings Ltd | Other | Cash Pre-Funded Warrants | 461,538 | $0.00 | - | |
| Saba Capital Management, L.P. - 10% Owner | Open-market sale | Common Stock | 25,000 | $2.30 | $57K | |
| Saba Capital Management, L.P. - 10% Owner | Open-market sale | Common Stock | 12,182 | $2.37 | $29K | |
| Saba Capital Management, L.P. - 10% Owner | Open-market sale | Common Stock | 29,777 | $2.19 | $65K | |
| Saba Capital Management, L.P. - 10% Owner | Open-market sale | Common Stock | 77,688 | $2.25 | $175K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $12.48 | $62K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $11.84 | $59K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $12.00 | $60K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $12.50 | $63K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $11.22 | $56K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $10.63 | $53K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 5,000 | $10.50 | $53K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 4,682 | $9.69 | $45K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 118 | $9.63 | $1K | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 100 | $9.60 | $960 | |
| Timothy James Ruemler - Director | Open-market purchase | Common Stock | 100 | $9.69 | $969 | |
| Timothy James Ruemler - Director | Open-market purchase | Option (right to buy) | 80,000 | $6.41 | $513K | |
| Jason L. Monroe - Director | Open-market purchase | Option (right to buy) | 80,000 | $6.41 | $513K | |
| Andrew R. Crescenzo - Officer | Open-market purchase | Option (right to buy) | 40,000 | $6.41 | $256K | |
| Robert Michael Hayes - Director | Open-market purchase | Option (right to buy) | 100,000 | $6.41 | $641K | |
| Soren Bo Christiansen - Director | Open-market purchase | Option (right to buy) | 80,000 | $6.41 | $513K | |
| Brenda Baird Simpson - Director | Open-market purchase | Option (right to buy) | 20,000 | $6.41 | $128K | |
| Paul K. Danner - Director | Open-market purchase | Option (right to buy) | 400,000 | $6.41 | $2.56M | |
| Timothy James Ruemler - Director | Open-market sale | Common Stock | 5,000 | $16.58 | $83K | |
| Timothy James Ruemler - Director | Open-market sale | Common Stock | 5,000 | $16.54 | $83K | |
| Timothy James Ruemler - Director | Open-market sale | Common Stock | 5,000 | $17.09 | $85K | |
| Timothy James Ruemler - Director | Open-market sale | Common Stock | 5,000 | $16.75 | $84K | |
 Yuwen Zhang - Officer | Grant or award | Stock Option | 500,000 | $0.00 | - | |
| Paul K. Danner - Director | Open-market purchase | Series B Preferred Stock | 5 | $20.00 | $100 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 300 | $582.00 | $582 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 500 | $585.00 | $975 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 100 | $591.00 | $197 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 300 | $594.00 | $594 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 100 | $597.00 | $199 | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 700 | $600.00 | $1K | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 800 | $603.00 | $2K | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 500 | $606.00 | $1K | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 700 | $588.00 | $1K | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 500 | $633.00 | $1K | |
| Robert Michael Hayes - Officer | Open-market purchase | Common Stock | 500 | $648.00 | $1K | |
Item 8.01, 9.01
Item 8.01, 9.01
Item 5.07
Item 8.01
STSS insider trading FAQ
What is the latest insider trade for STSS?
Sharps Technology Inc. (STSS) had 1 insider filing in the last 90 days, with the most recent on 9 October 2026. The full record for STSS runs to 15 Form 4 filings, the earliest from 5 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STSS stock?
1 insider purchase of STSS was filed in the last 90 days, totaling $78K.
How many insiders are selling STSS stock?
No insider sales of STSS were filed in the last 90 days. 12 sales are on record for this company.
Where can I see STSS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STSS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Bastion Trading Ltd view on EDGAR
- - FalconX Holdings Ltd view on EDGAR
- - Saba Capital Management, L.P. view on EDGAR
- - Saba Capital Management, L.P. view on EDGAR
- - Timothy James Ruemler view on EDGAR
- - Jason L. Monroe view on EDGAR
- - Andrew R. Crescenzo view on EDGAR
- - Robert Michael Hayes view on EDGAR
- - Soren Bo Christiansen view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where STSS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STSS with a 7-day demo
- STSS on your watchlist
- Every STSS Form 4 filing on record
- Up to 3 months of STSS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
